SV EN

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

06 May 2020

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis according to an article from a European study, recently published in Nature. The mechanisms are not specified, but the results are still clear in this first large publication from the EU-based collaborative project MetaCardis, where Fredrik Bäckhed is one of 14 research groups from six countries. 

To the article in Nature:
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Learn more about MetaCardis:
http://www.metacardis.net/

This site uses cookies, by continuing you agree to the use of cookies